Wealth Architects, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Wealth Architects, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2022$234,000
+6.4%
5,0180.0%0.05%
+14.0%
Q2 2022$220,000
-39.2%
5,018
+0.4%
0.04%
-30.6%
Q1 2022$362,000
-10.6%
5,0000.0%0.06%
-12.7%
Q4 2021$405,000
-30.4%
5,0000.0%0.07%
-37.2%
Q3 2021$582,000
-29.8%
5,0000.0%0.11%
-30.2%
Q2 2021$829,000
+18.8%
5,0000.0%0.16%
+7.3%
Q1 2021$698,000
-19.4%
5,0000.0%0.15%
-24.9%
Q4 2020$866,000
+24.2%
5,0000.0%0.20%
+6.3%
Q3 2020$697,000
+16.8%
5,0000.0%0.19%
+13.2%
Q2 2020$597,000
+19.4%
5,0000.0%0.17%
-3.5%
Q1 2020$500,000
-15.0%
5,0000.0%0.17%
+5.5%
Q4 2019$588,000
+36.7%
5,0000.0%0.16%
+25.2%
Q3 2019$430,000
+32.7%
5,0000.0%0.13%
+33.7%
Q2 2019$324,000
+3.5%
5,0000.0%0.10%0.0%
Q1 2019$313,000
+9.8%
5,0000.0%0.10%
+11.4%
Q3 2018$285,000
-28.6%
5,0000.0%0.09%
-31.8%
Q2 2018$399,000
-7.9%
5,0000.0%0.13%
-9.8%
Q1 2018$433,000
+25.5%
5,0000.0%0.14%
+26.5%
Q4 2017$345,000
-24.0%
5,0000.0%0.11%
-28.5%
Q3 2017$454,000
+22.0%
5,0000.0%0.16%
+14.5%
Q2 2017$372,000
-20.7%
5,000
-0.1%
0.14%
-25.8%
Q1 2017$469,000
+29.2%
5,004
+0.1%
0.19%
+14.8%
Q4 2016$363,000
-30.3%
5,0000.0%0.16%
-32.8%
Q3 2016$521,000
+41.6%
5,0000.0%0.24%
+35.4%
Q2 2016$368,000
+31.0%
5,0000.0%0.18%
+27.1%
Q1 2016$281,000
-16.9%
5,0000.0%0.14%
-16.2%
Q4 2015$338,0005,0000.17%
Other shareholders
NEVRO CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 562,833$40,710,0004.84%
Altium Capital Management LP 77,000$5,569,0001.86%
PFM Health Sciences, LP 649,513$46,979,0001.76%
Rock Springs Capital Management LP 721,500$52,186,0001.31%
Integral Health Asset Management, LLC 50,000$3,617,0000.94%
Redmile Group, LLC 411,017$29,729,0000.93%
K2 PRINCIPAL FUND, L.P. 114,800$8,303,0000.72%
Connacht Asset Management LP 18,762$1,357,0000.70%
Perceptive Advisors 477,037$34,504,0000.69%
ArrowMark Colorado Holdings LLC 855,439$61,874,0000.54%
View complete list of NEVRO CORP shareholders